Olopatadine-PPDS
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Olopatadine-PPDS, covering 2013-09-17 to 2013-09-17. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of the QLT Proprietary Olopatadine-PPDS in Subjects With Seasonal Allergic Conjunctivitis to Ragweed in an Environmental Exposure Chamber Model. [Phase 2]